rs149219369

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000292.3(PHKA2):​c.742A>C​(p.Arg248Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,172,943 control chromosomes in the GnomAD database, including 3 homozygotes. There are 602 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., 42 hem., cov: 23)
Exomes 𝑓: 0.0018 ( 3 hom. 560 hem. )

Consequence

PHKA2
NM_000292.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.63

Publications

3 publications found
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXa1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • glycogen storage disease due to liver phosphorylase kinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant X-18941651-T-G is Benign according to our data. Variant chrX-18941651-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.63 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0013 (147/113213) while in subpopulation NFE AF = 0.0023 (123/53430). AF 95% confidence interval is 0.00197. There are 0 homozygotes in GnomAd4. There are 42 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 42 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA2NM_000292.3 linkc.742A>C p.Arg248Arg synonymous_variant Exon 8 of 33 ENST00000379942.5 NP_000283.1 P46019

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA2ENST00000379942.5 linkc.742A>C p.Arg248Arg synonymous_variant Exon 8 of 33 1 NM_000292.3 ENSP00000369274.4 P46019

Frequencies

GnomAD3 genomes
AF:
0.00130
AC:
147
AN:
113213
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000416
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000747
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00230
Gnomad OTH
AF:
0.00197
GnomAD2 exomes
AF:
0.00119
AC:
219
AN:
183338
AF XY:
0.00114
show subpopulations
Gnomad AFR exome
AF:
0.000304
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00235
Gnomad OTH exome
AF:
0.000884
GnomAD4 exome
AF:
0.00184
AC:
1949
AN:
1059730
Hom.:
3
Cov.:
25
AF XY:
0.00170
AC XY:
560
AN XY:
330144
show subpopulations
African (AFR)
AF:
0.000117
AC:
3
AN:
25708
American (AMR)
AF:
0.000654
AC:
23
AN:
35179
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19147
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30055
South Asian (SAS)
AF:
0.0000375
AC:
2
AN:
53293
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40516
Middle Eastern (MID)
AF:
0.000494
AC:
2
AN:
4050
European-Non Finnish (NFE)
AF:
0.00229
AC:
1844
AN:
806909
Other (OTH)
AF:
0.00163
AC:
73
AN:
44873
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
64
128
193
257
321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00130
AC:
147
AN:
113213
Hom.:
0
Cov.:
23
AF XY:
0.00119
AC XY:
42
AN XY:
35341
show subpopulations
African (AFR)
AF:
0.000416
AC:
13
AN:
31227
American (AMR)
AF:
0.000747
AC:
8
AN:
10715
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3630
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2807
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6293
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.00230
AC:
123
AN:
53430
Other (OTH)
AF:
0.00197
AC:
3
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00189
Hom.:
13
Bravo
AF:
0.00137
EpiCase
AF:
0.00229
EpiControl
AF:
0.00261

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 23, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disease IXa1 Benign:1
Nov 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
9.1
DANN
Benign
0.72
PhyloP100
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149219369; hg19: chrX-18959769; COSMIC: COSV66054365; API